ClinicalTrials.Veeva

Menu

LDH as a Biochemical Biomarker to Predict Organ Failure in the Emergency Department Setting

Karolinska Institute logo

Karolinska Institute

Status

Completed

Conditions

Multiple Organ Failure

Study type

Observational

Funder types

Other

Identifiers

NCT01937676
K3-akuten

Details and patient eligibility

About

The purpose of this study is evaluate if K3, a novel biomarker, sampled at arrival to the emergency department can be used to predict the development of organ failure measured as SOFA score. K3 consists of lactate dehydrogenase, albumin and magnesium combined.

Enrollment

1,250 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥18 years
  • Admitted to emergency department, Karlstad Central Hospital, Sweden

Exclusion criteria

  • Not in need of venous blood sample

Trial design

1,250 participants in 1 patient group

Adults admitted to ER
Description:
All adult patients admitted to emergency department during the study period.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems